Home E-Weekly April 18, 2017

News & Notes

Published: April 17, 2017

  • Isomeric recalls sterile compounded products over FDA concerns Isomeric Pharmacy Solutions, a 503B compounding lab based in Salt Lake City, Utah, has voluntarily recalled all lots of its sterile compounded medications distributed between Oct. 4, 2016, and Feb. 7, 2017. Isomeric hasn't received any reports of adverse events related to this recall, but has taken this action as a precautionary measure in light of FDA concerns regarding "a lack of sterility assurance." Anyone who has received the affected medications should immediately discontinue the use of and quarantine any unused product. Contact Isomeric by phone — (844) 470-2467 — or email to arrange the return of any unused sterile compounded products.
  • Can stem cells rejuvenate knees? There's hope on the horizon for the 30% of Americans with degenerative knee cartilage, according to Adam Anz, MD, an orthopedic surgeon at the Andrews Institute for Orthopaedics & Sports Medicine in Gulf Breeze, Fla. He'll soon launch research aimed at increasing the amount of stem cells surgeons can harvest from bone marrow transplants to regrow damaged cartilage. He hopes the study will lead to a cost-effective treatment for long-suffering patients.
  • In defense of the ACS surgical risk calculator Though not perfect, the American College of Surgeons surgical risk calculator is both accurate and appropriate across many surgical domains, a new study finds. Researchers say reported failures tend to be associated with small sample sizes, homogeneity and/or limited data, and should not be misunderstood to disqualify the calculator as a useful tool.
New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

"As Surgery Centers Boom, Patients Are Paying With Their Lives"

News & Notes

Can Caffeine Give a Jolt to Post-op Pain Relief?